Here Are Some Essential Facts About STERIS

By Harris Dyer • Monday, November 21 11:11 • Permanent Link

With gains of 8.0%, STERIS was one of the winners on Wall Street today. Its shares are now trading at $178.72 and have logged a -0.5% daily outperformance of the S&P 500. Don't join the feeding frenzy before checking some basic facts about this stock:

STERIS has moved -28.1% over the last year, and the S&P 500 logged a change of -15.3%
STE has an average analyst rating of buy and is -19.13% away from its mean target price of $221 per share
Its trailing earnings per share (Eps) is $3.82
STERIS has a trailing 12 month Price to Earnings (P/E) ratio of 46.8 while the S&P 500 average is 15.97
Its forward earnings per share (Eps) is $9.24 and its forward P/E ratio is 19.3
The company has a Price to Book (P/B) ratio of 3.1 in contrast to the S&P 500's average ratio of 2.95
STERIS is part of the Healthcare sector, which has an average P/E ratio of 13.21 and an average P/B of 4.07
The company has a free cash flow of $489,910,112.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.